RIGL financials
Rigel Pharmaceuticals (RIGL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RIGL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $294.28M | $274.66M | $125.47M | $367.02M | 19.48 |
| 2024 | $179.28M | $160.63M | $24.19M | $17.48M | 0.99 |
| 2023 | $116.88M | $109.77M | -$20.49M | -$25.09M | -1.44 |
| 2022 | $120.24M | $118.49M | -$55.55M | -$58.57M | -3.40 |
| 2021 | $149.24M | $148.15M | -$12.50M | -$17.91M | -1.10 |
| 2020 | $108.62M | $107.73M | -$28.97M | -$29.74M | -1.80 |
- RIGL revenue was $294.28M in fiscal 2025, net income $367.02M.
Updated 2026-11-05 12:51 UTC